P33981 (TTK_HUMAN) Homo sapiens (Human)

Dual specificity protein kinase TTK UniProtKBInterProSTRINGInteractive Modelling

857 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

78 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepi…homo-4-mer519-794
100.0MG;92M;
HUMAN MPS1 IN COMPLEX WITH NMS-P715homo-2-mer515-795
100.0SVE;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …homo-2-mer516-794
98.845NW;DMS;
Crystal structure of TTK kinase domainmonomer515-796
100.0
Crystal structure of TTK kinase domain in complex with compound 7monomer515-795
100.0FZR;
Crystal structure of human Mps1 catalytic domain in complex with the inhibitor staurosporinemonomer514-794
100.07PE;STU;IPA;GOL;
Crystal structure of TTK kinase domain in complex with compound 9monomer515-795
100.0FZL;
Human Mps1 kinase domain with ordered activation loopmonomer515-795
100.0GOL;CL;
Crystal structure of TTK kinase domain in complex with compound 28monomer515-795
100.0G0U;
Human TTK in complex with a Dyrk1B inhibitormonomer513-793
99.6DYK;
Crystal Structure of TTK kinase domain with an inhibitor: 400740monomer515-794
100.0PO4;1PH; 10×EDO;
Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitormonomer516-795
100.0GOL;PEG;EDO;052;
Crystal structure of TTK kinase domain in complex with compound 30monomer515-794
100.0FZO;MG;
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridi…monomer516-795
100.0IOD;O22;
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16monomer515-794
100.0NN5;
Crystal structure of the human TTK in complex with an inhibitormonomer515-794
100.0KE7;1PE;EDO;
Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol…monomer516-795
100.01O5;
Crystal structure of human Mps1 catalytic domain T686A mutant in complex with SP600125 inhibitormonomer516-795
99.61537;7PE;
Crystal structure of TTK kinase domain in complex with compound 19monomer516-795
100.0G5C;
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1…monomer516-795
100.0IOD;O38;
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)-3-(4-((6-(((3s,5s,7s)-adamanta…monomer516-795
100.0O17;
Crystal structure of TTK kinase domain with an inhibitor: 401348monomer515-793
100.01PF;SO4;PEG;GOL;
Crystal structure of human Mps1 catalytic domain in complex with a quinazolin ligand Compound 4monomer516-794
100.0CX4;7PE;PEG;GOL;IPA;
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-yl…monomer516-794
100.0CL;O23;
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46monomer516-794
100.0O23;CL;
Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]…monomer515-793
100.02QK;GOL;
Crystal structure of TTK kinase domain in complex with compound 8monomer516-794
100.0FZF;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer516-794
98.835O7;
Crystal structure of human Mps1 catalytic domain in complex with ATPmonomer516-794
100.0ATP;7PE;
Crystal structure of human Mps1 (TTK) C604Y mutant in complex with NMS-P715monomer519-797
99.63SVE;EDO;
CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrah…monomer516-794
100.0O43;
TTK in Complex with Inhibitormonomer515-793
100.0CQ7;CAC;
Crystal structure of human mitotic checkpoint kinase Mps1 catalytic domain apo formmonomer516-794
100.07PE;
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79monomer516-793
100.08RH;
X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 41monomer517-794
100.08QW;CL;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer519-796
100.00SQ;
Crystal structure of human Mps1 (TTK) C604W mutant in complex with Cpd-5monomer519-796
99.62C5N;EDO;
Structure of Human MPS1 (TTK) covalently bound to RMS-07 inhibitormonomer519-795
100.0YB4;GOL;TOE;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-795
100.0O38;GOL;MG;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-795
100.0AU5;P4C;DMS; 13×EDO;
Crystal structure of human Mps1 (TTK) in complex with Cpd-5monomer519-795
99.61C5N; 12×EDO;CL;
Crystal structure of human Mps1 (TTK) in complex with Reversinemonomer519-795
99.61AD5;EDO;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer519-794
100.05OQ;DMS;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
99.61PWU; 10×EDO;DMS;
TTK kinase domain in complex with TC-Mps1-12monomer519-794
100.08QE;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer519-794
100.05O1;DMS;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer519-794
100.07PE;5O4;EDO;DMS;
TTK kinase domain in complex with NTRC 0066-0monomer519-794
100.0N66;PGF;NA;
TTK kinase domain in complex with BAY 1161909monomer519-794
100.08QW;
Crystal structure of human dual specificity protein kinase (TTK)monomer519-794
100.07PE;
TTK kinase domain in complex with Mps-BAY2bmonomer519-794
100.08Q5;NA;PG0;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.07PE;7CE;EDO;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
99.61SVE;EDO;DMS;
Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enab…monomer519-794
100.0FMW;7PE;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.0X21;
MPS1 kinase with 3-aminopyridin-2-one inhibitorsmonomer519-794
100.0W2K;EDO;DMS;
MPS1 kinase with 3-aminopyridin-2-one inhibitorsmonomer519-794
100.0WBI;DMS;EDO;
TTK kinase domain in complex with MPI-0479605monomer519-794
100.08PT;7PE;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.04T9;1PE;7PE;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.07RO;7PE;EDO;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.0X20;7PE;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
99.67PE;AU5;DMS;EDO;
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitormonomer519-794
100.07PE;ZO6;EDO;
Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrolo-pyridin l…monomer519-794
100.0S22;7PE;
TTK kinase domain in complex with BAY 1217389monomer519-794
100.08RH;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
100.0PWU;
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1monomer519-794
100.07RO;7PE;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
99.67RO;1KA;PGE;EDO;
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitormonomer519-794
100.07PE;Z0W;EDO;
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.monomer519-794
99.61O38;7PE;EDO;
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitormonomer519-794
100.07PE;Z0B;EDO;
TTK kinase domain in complex with a PEG-linked pyrimido-indolizinemonomer519-794
100.08QZ;
MPS1 kinase with 3-aminopyridin-2-one inhibitorsmonomer519-794
100.03D7;EDO;
Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitormonomer519-794
100.0EDO;7PE;ZO8;
Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a …monomer519-753
100.05OE;DMS;
Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin…monomer59-199
100
Crystal structure of human Mps1 TPR domainmonomer62-199
100PG4;GOL;
Crystal structure of the tetratricopeptide repeat (TPR) motif of human dual specificity protein kin…monomer59-196
100PB;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6gvj.1.Amonomer0.76515-795
100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26gvj.1.Amonomer0.76514-794
100.00